Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Die Medizinische Welt
|
February 18, 1983
[Preliminary medical exams: whose problem? A current short analysis]
R Diel, G Einhorn, M Gerspach, et al.
The European Respiratory Journal
|
May 17, 2007
Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis
R Diel, P Wrighton-Smith, J-P Zellweger
Pneumologie (Stuttgart, Germany)
|
January 21, 2016
[Tuberculosis and Tobacco Smoking]
R Loddenkemper, M Brönnecke, S Castell, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 10, 2006
[Current position regarding the diagnosis of tuberculosis]
C Lange, T Schaberg, R Diel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Costs and Effectiveness of Combination Therapy with Bedaquiline and other Anti-Tuberculosis Drugs in Patients with Multi- and Extensively Drug-Resistant Tuberculosis in Germany
L Wolfson, D Wirth, J Jibbert, et al.
Zeitschrift Fur Rheumatologie
|
June 11, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]
R Diel, B Hauer, R Loddenkemper, et al.
Pneumologie (Stuttgart, Germany)
|
April 25, 2007
[Latent tuberculosis infection in healthcare workers--evaluation of an Interferon-gamma release assay]
A Nienhaus, R Loddenkemper, B Hauer, et al.
Pneumologie (Stuttgart, Germany)
|
June 12, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]
R Diel, B Hauer, R Loddenkemper, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
August 18, 2020
Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany
R Diel, M Obradovic, S Tyler, et al.
Respiratory Medicine
|
August 18, 2009
Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany
R Diel, T Schaberg, R Loddenkemper, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Die Medizinische Welt
|
February 18, 1983
[Preliminary medical exams: whose problem? A current short analysis]
R Diel, G Einhorn, M Gerspach, et al.
The European Respiratory Journal
|
May 17, 2007
Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis
R Diel, P Wrighton-Smith, J-P Zellweger
Pneumologie (Stuttgart, Germany)
|
January 21, 2016
[Tuberculosis and Tobacco Smoking]
R Loddenkemper, M Brönnecke, S Castell, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 10, 2006
[Current position regarding the diagnosis of tuberculosis]
C Lange, T Schaberg, R Diel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Costs and Effectiveness of Combination Therapy with Bedaquiline and other Anti-Tuberculosis Drugs in Patients with Multi- and Extensively Drug-Resistant Tuberculosis in Germany
L Wolfson, D Wirth, J Jibbert, et al.
Zeitschrift Fur Rheumatologie
|
June 11, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]
R Diel, B Hauer, R Loddenkemper, et al.
Pneumologie (Stuttgart, Germany)
|
April 25, 2007
[Latent tuberculosis infection in healthcare workers--evaluation of an Interferon-gamma release assay]
A Nienhaus, R Loddenkemper, B Hauer, et al.
Pneumologie (Stuttgart, Germany)
|
June 12, 2009
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]
R Diel, B Hauer, R Loddenkemper, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
August 18, 2020
Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany
R Diel, M Obradovic, S Tyler, et al.
Respiratory Medicine
|
August 18, 2009
Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany
R Diel, T Schaberg, R Loddenkemper, et al.
Page
of 6